A new Swedish study by Reis & Kallen describes approximately 15 000 women (and their babies) that, between 1995 and 2007, reported the use of antidepressants, or were prescribed such drugs, during pregnancy. In this study, pregnancy and teratogenic outcomes after exposure to tricyclic antidepressants are, for most measures, equal or worse than after exposure to selective serotonin reuptake inhibitors or other antidepressants. Based on this and on a review of the few other studies available (admittedly, a relatively small number of women on which conclusions can be based), the authors of this Editorial challenge the 'perinatal myth' that tricyclics are the safest choice in pregnancy.
Original languageEnglish
Pages (from-to)15 - 17
Number of pages3
JournalPsychological Medicine
Issue number1
Publication statusPublished - Jan 2011


Dive into the research topics of 'Should we stop using tricyclic antidepressants in pregnancy?'. Together they form a unique fingerprint.

Cite this